Comment
doi: 10.1016/S1470-2045(17)30085-2.
Epub 2017 Feb 22.
Predicting outcomes after a positive interim FDG-PET scan in advanced Hodgkin's lymphoma
Affiliations
- PMID: 28237632
- DOI: 10.1016/S1470-2045(17)30085-2
Item in Clipboard
Comment
Predicting outcomes after a positive interim FDG-PET scan in advanced Hodgkin's lymphoma
Lancet Oncol.
2017 Apr.
No abstract available
Comment on
-
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.Lancet Oncol. 2017 Apr;18(4):454-463. doi: 10.1016/S1470-2045(17)30103-1. Epub 2017 Feb 22. Lancet Oncol. 2017. PMID: 28236583 Clinical Trial.
Similar articles
-
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET.Ann Nucl Med. 2008 Jun;22(5):429-32. doi: 10.1007/s12149-008-0105-8. Epub 2008 Jul 4. Ann Nucl Med. 2008. PMID: 18600422
-
FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.Q J Nucl Med Mol Imaging. 2008 Mar;52(1):9-16. Q J Nucl Med Mol Imaging. 2008. PMID: 18235420
-
Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained.Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1254-1257. doi: 10.1007/s00259-017-3714-4. Eur J Nucl Med Mol Imaging. 2017. PMID: 28466283 No abstract available.
-
18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?J Nucl Med. 2008 Jan;49(1):9-12. doi: 10.2967/jnumed.107.046292. Epub 2007 Dec 12. J Nucl Med. 2008. PMID: 18077522 Review. No abstract available.
-
Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.Q J Nucl Med. 2001 Sep;45(3):269-73. Q J Nucl Med. 2001. PMID: 11788819 Review.
Cited by
-
Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.Cochrane Database Syst Rev. 2019 Sep 16;9(9):CD012643. doi: 10.1002/14651858.CD012643.pub2. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2020 Jan 13;1:CD012643. doi: 10.1002/14651858.CD012643.pub3. PMID: 31525824 Free PMC article. Updated.
-
Total Lesion Glycolysis Estimated by a Radiomics Model From CT Image Alone.Front Oncol. 2021 Jun 17;11:664346. doi: 10.3389/fonc.2021.664346. eCollection 2021. Front Oncol. 2021. PMID: 34221979 Free PMC article.
-
Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies.Cochrane Database Syst Rev. 2020 Jan 13;1(1):CD012643. doi: 10.1002/14651858.CD012643.pub3. Cochrane Database Syst Rev. 2020. PMID: 31930780 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
